Back

Effect of Icosapent Ethyl on Changes in Coronary Plaque Morphology: EVAPORATE

17 April 2021 (15:58 - 16:02)
Organised by:
Congress Presentation Part of: Late-Breaking Science: be the first to know! Lipid-Lowering Agents EAPC Premium Access ESC Preventive Cardiology 2021

About the speaker

Photo
Mr Andrew Buckler

Karolinska Institutet, Stockholm (Sweden)

5 More presentations in this session

Presentation thumbnail
Effectiveness of an ambulatory virtual cardiac rehabilitation program versus traditional cardiac rehabilitation: a randomized controlled study.
Doctor J. Gomez Polo (Madrid, ES)
Video
Presentation thumbnail
Cytochrome P450 polymorphisms and left ventricular failure following percutaneous coronary intervention
Professor N. Abdelmoula (Sfax, TN)
Video
Presentation thumbnail
The hypotensive effects of home-based isometric handgrip training in older adults with pre-hypertension and hypertension
Mr D. Pinto (Guimaraes, PT)
Video
Presentation thumbnail
Intermediate-dose versus standard-dose prophylactic anticoagulation in patients with COVID-19 admitted to the intensive care unit: Final results from the INSPIRATION randomized trial
Professor P. Sadeghipour (Tehran, IR)
Video
Presentation thumbnail
Late-Breaking Science: be the first to know! Discussion.

Access the full session

Session thumbnail
Late-Breaking Science: be the first to know!
Video

The Event

Event poster

ESC Preventive Cardiology 2021

17 April 2021 15:58 CET
You may be interested in
thumbnail
Congress Presentation
Where are we now? Decision-making in LDL-C lowering and CV risk
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Congress Presentation
2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources